(Q51791702)

12 April 2018

title

Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study. (English)

1 reference

12 April 2018

author name string

Cremer DR

1

1 reference

12 April 2018

Rabeler R

2

1 reference

12 April 2018

Roberts A

3

1 reference

12 April 2018

Lynch B

4

1 reference

12 April 2018

language of work or name

English

0 references

publication date

8 August 2006

1 reference

12 April 2018

Regulatory Toxicology and Pharmacology

published in

1 reference

12 April 2018

volume

46

1 reference

12 April 2018

issue

3

1 reference

12 April 2018

page(s)

193-201

1 reference

12 April 2018

[Stage-photometric determination of hemoglobin by means of cyanhemoglobin]

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

The pharmacology of the antioxidant lipoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

The role of antioxidant micronutrients in the prevention of diabetic complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Safety evaluation of alpha-lipoic acid (ALA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Alpha-lipoic acid protects the retina against ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Alpha-lipoic acid: a multifunctional antioxidant that improves insulin sensitivity in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Acute, subacute and chronic toxicities of thioctic acid in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Beneficial effects of alpha-lipoic acid plus vitamin E on neurological deficit, reactive gliosis and neuronal remodeling in the penumbra of the ischemic rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Exercise training and the antioxidant alpha-lipoic acid in the treatment of insulin resistance and type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Enantioselective pharmacokinetics and bioavailability of different racemic α-lipoic acid formulations in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Anti-obesity effects of alpha-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Comparison of the effect of α-lipoic acid and α-tocopherol supplementation on measures of oxidative stress

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Molecular aspects of lipoic acid in the prevention of diabetes complications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

From lipoic acid to multi-enzyme complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Treatment of diabetic polyneuropathy with the antioxidant thioctic acid (alpha-lipoic acid): a two year multicenter randomized double-blind placebo-controlled trial (ALADIN II). Alpha Lipoic Acid in Diabetic Neuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Effects of 3-week oral treatment with the antioxidant thioctic acid (alpha-lipoic acid) in symptomatic diabetic polyneuropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Treatment for diabetic mononeuropathy with alpha-lipoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Alpha-lipoic acid induces p27Kip-dependent cell cycle arrest in non-transformed cell lines and apoptosis in tumor cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

α-Lipoic Acid and Cardiovascular Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Serum glutamic pyruvic transaminase in cardiac with hepatic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

Alpha-lipoic acid in the treatment of diabetic polyneuropathy in Germany: current evidence from clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2006.06.003

10.1016/J.YRTPH.2006.06.003

7 January 2021

Identifiers

DOI

1 reference

12 April 2018

release_yhkexhhanza7tooyfmpdmx2yli

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/yhkexhhanza7tooyfmpdmx2yli

mapped directly with Wikidata item

24 November 2022

based on heuristic

PubMed ID

16899332

1 reference

12 April 2018